This program was developed to provide Canadian health professionals with the training they need to treat patients suffering from opioid use disorder with ^NSUBOXONE^MD (buprenorphrine in the form of hydrochloride and naloxone in the form of hydrochloride).

Contact information

Indivior Canada
Email: infoMIU@indivior.com
Phone: 1-877-782‐ 6966